Filing Flows › Vaxart (VXRT) › Government Contract revenue
Vaxart (VXRT) Government Contract revenue by quarter
Vaxart's Government Contract revenue was $7.5M in Q3 2026 (third quarter 2026), -69% from Q2 2026. Over the last 4 quarters it ranged from $7.5M (Q3 2026) to $36.4M (Q1 2026).
| Quarter | Government Contract revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $7.5M | -69% | — |
| Q2 2026 | $24.3M | -33% | — |
| Q1 2026 | $36.4M | +88% | +88% |
| Q1 2025 | $19.3M | — | — |
Q3 2026 at a glance
Vaxart, Q3 2026: revenue $10.6M (-85% year over year), operating margin -162.7%, net loss $17.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Vaxart's Government Contract revenue?
Vaxart's Government Contract revenue was $7.5M in Q3 2026 (third quarter 2026), -69% from Q2 2026.
How has Vaxart's Government Contract revenue changed?
Over the last 4 quarters it ranged from $7.5M (Q3 2026) to $36.4M (Q1 2026).